Equities Research Analysts’ Price Target Changes for June, 20th (ARCT, BHC, BKG, BRY, CHK, CLR, CTST, DNLM, DNR, FDX)

Equities Research Analysts’ price target changes for Thursday, June 20th:

Arcturus Therapeutics (NASDAQ:ARCT) was given a $18.00 price target by analysts at Chardan Capital. The firm currently has a buy rating on the stock.

Bausch Health Companies (NYSE:BHC) was given a $45.00 price target by analysts at Mizuho. The firm currently has a buy rating on the stock.

Berkeley Group (LON:BKG) had its price target trimmed by Canaccord Genuity from GBX 3,980 ($52.01) to GBX 3,850 ($50.31). The firm currently has a buy rating on the stock.

Berry Petroleum (NASDAQ:BRY) was given a $14.00 price target by analysts at UBS Group AG. The firm currently has a buy rating on the stock.

Chesapeake Energy (NYSE:CHK) was given a $2.00 price target by analysts at UBS Group AG. The firm currently has a sell rating on the stock.

Continental Resources (NYSE:CLR) was given a $45.00 target price by analysts at UBS Group AG. The firm currently has a hold rating on the stock.

CannTrust (NYSE:CTST) was given a $7.00 target price by analysts at Bank of America Corp. The firm currently has a buy rating on the stock.

Dunelm Group (LON:DNLM) had its price target raised by UBS Group AG from GBX 920 ($12.02) to GBX 930 ($12.15). The firm currently has a neutral rating on the stock.

Denbury Resources (NYSE:DNR) was given a $2.00 price target by analysts at UBS Group AG. The firm currently has a hold rating on the stock.

FedEx (NYSE:FDX) was given a $205.00 price target by analysts at Sanford C. Bernstein. The firm currently has a buy rating on the stock.

Forum Energy Technologies (NYSE:FET) was given a $5.00 price target by analysts at Citigroup Inc. The firm currently has a buy rating on the stock.

Arcimoto (NASDAQ:FUV) was given a $10.00 price target by analysts at Chardan Capital. The firm currently has a buy rating on the stock.

MSG Networks (NYSE:MSGN) was given a $23.00 target price by analysts at Rosenblatt Securities. The firm currently has a hold rating on the stock.

Nike (NYSE:NKE) was given a $103.00 target price by analysts at Morgan Stanley. The firm currently has a buy rating on the stock.

Intec Pharma (NASDAQ:NTEC) was given a $16.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Pacific Biosciences of California (NASDAQ:PACB) was given a $8.00 target price by analysts at Cantor Fitzgerald. The firm currently has a hold rating on the stock.

Simmons First National (NASDAQ:SFNC) was given a $29.00 price target by analysts at Stephens. The firm currently has a buy rating on the stock.

Stemline Therapeutics (NASDAQ:STML) was given a $35.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Taubman Centers (NYSE:TCO) was given a $45.00 price target by analysts at Morgan Stanley. The firm currently has a hold rating on the stock.

Veoneer (NYSE:VNE) was given a $26.00 target price by analysts at Longbow Research. The firm currently has a buy rating on the stock.

Vista Outdoor (NYSE:VSTO) was given a $13.00 target price by analysts at B. Riley. The firm currently has a buy rating on the stock.

Receive News & Ratings for Arcturus Therapeutics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcturus Therapeutics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit